From Red Herring:
Old drugs with minor variations, and therefore new patents, are behind the massive growth in spending on prescription medicines in developed countries, but do not offer substantial improvements over cheaper generic drugs, according to scientists at the University of British Columbia in Canada.
Known as “me-too” drugs, these medicines on average cost twice the price of the original brand-name drugs they are based on, and four times that of generic versions of the original drug. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment